Cargando…
Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review
Lung cancer is one of the leading causes of cancer-related deaths worldwide. However, there are currently limited treatment options that are widely available to patients with advanced lung cancer, and further research is required to inhibit or reverse disease progression more effectively. In lung an...
Autores principales: | Li, Yuting, Liu, Tongzuo, Wang, Xiaoqun, Jia, Yingjie, Cui, Huantian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467373/ https://www.ncbi.nlm.nih.gov/pubmed/37605558 http://dx.doi.org/10.1177/15330338231190545 |
Ejemplares similares
-
Biological Role and Mechanism of Lipid Metabolism Reprogramming
Related Gene ECHS1 in Cancer
por: Hu, Teng, et al.
Publicado: (2022) -
Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
por: Xu, Jiali, et al.
Publicado: (2023) -
Multi-omics Analysis of the Role of PHGDH in Colon
Cancer
por: Dai, Zhihui, et al.
Publicado: (2023) -
Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?
por: Quevedo-Ocampo, Jaqueline, et al.
Publicado: (2022) -
NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis
por: Sun, Linjuan, et al.
Publicado: (2023)